Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

Manoel Nunes, Patricia Vrignaud, Sophie Vacher, Sophie Richon, Astrid Lièvre, Wulfran Cacheux, Louis-Bastien Weiswald, Gerald Massonnet, Sophie Chateau-Joubert, André Nicolas, Colette Dib, Weidong Zhang, James Watters, Donald Bergstrom, Sergio Roman-Roman, Ivan Bièche, Virginie Dangles-Marie

Cancer Res (2015) 75 (8): 1560–1566.

https://doi.org/10.1158/0008-5472.CAN-14-1590

Published: 14 April 2015

View article titled, Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

Includes: Supplementary data

Journal Articles

Abstract 5055: Efficacy of cabazitaxel in mouse models of pediatric brain tumors.

James M. Olson, Emily Girard, Sally Ditzler, Andrew Richards, Doonhoon Lee, Patricia Vrignaud

Cancer Res (2013) 73 (8_Supplement): 5055.

https://doi.org/10.1158/1538-7445.AM2013-5055

Published: 15 April 2013

View article titled, Abstract 5055: Efficacy of cabazitaxel in mouse models of pediatric brain tumors.

Journal Articles

Abstract 5508: Antitumor activity of cabazitaxel in pediatric patient-derived tumor xenografts (PDX).

Patricia Vrignaud

Cancer Res (2013) 73 (8_Supplement): 5508.

https://doi.org/10.1158/1538-7445.AM2013-5508

Published: 15 April 2013

View article titled, Abstract 5508: Antitumor activity of cabazitaxel in pediatric patient-derived tumor xenografts (PDX).

Journal Articles

Abstract LB-34: Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients.

Manoel Nunes, Louis-Bastien Weiswald, Patricia Vrignaud, Sophie Vacher, Edouard Turlotte, Sophie Richon, Dominique Bellet, Sergio Roman-Roman, Ivan Bieche, Virginie Dangles-Marie

Cancer Res (2013) 73 (8_Supplement): LB-34.

https://doi.org/10.1158/1538-7445.AM2013-LB-34

Published: 15 April 2013

View article titled, Abstract LB-34: Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients.

Journal Articles

Abstract 2785: Development program of patient tumor tissue bank to support the drug and target discovery.

Marc Hillairet de Boisferon, Francis Bichat, Caroline Mignard, Loïc Morgand, Lydia Blot, Corinne Venot, Ana Merino-Trigo, Patricia Vrignaud

Cancer Res (2013) 73 (8_Supplement): 2785.

https://doi.org/10.1158/1538-7445.AM2013-2785

Published: 15 April 2013

View article titled, Abstract 2785: Development program of patient tumor tissue bank to support the drug and target discovery.

Journal Articles

Abstract 2775: Antitumor activity of cabazitaxel in pediatric tumor xenografts

Sukhvinder S. Sidhu, Marc Malfilatre, Claire Janvier, Elisabeth Boulcourt-Sambou, Loïc Vincent, Loreley Calvet, Patricia Vrignaud

Cancer Res (2012) 72 (8_Supplement): 2775.

https://doi.org/10.1158/1538-7445.AM2012-2775

Published: 15 April 2012

View article titled, Abstract 2775: Antitumor activity of cabazitaxel in pediatric tumor xenografts

Journal Articles

Abstract 2522: Therapeutic synergism of cabazitaxel in combination with cisplatin in tumor-bearing mice

Patricia Vrignaud

Cancer Res (2011) 71 (8_Supplement): 2522.

https://doi.org/10.1158/1538-7445.AM2011-2522

Published: 15 April 2011

View article titled, Abstract 2522: Therapeutic synergism of cabazitaxel in combination with cisplatin in tumor-bearing mice

Journal Articles

Abstract 4169: CReMEC initiative: Characterization of patient-derived colorectal tumor models and correlation with patient profile

Cancer Res (2010) 70 (8_Supplement): 4169.

https://doi.org/10.1158/1538-7445.AM10-4169

Published: 15 April 2010

View article titled, Abstract 4169: CReMEC initiative: Characterization of patient-derived colorectal tumor models and correlation with patient profile

Journal Articles

Abstract 714: Non-invasive monitoring of the antitumor activity of SAR650984 anti-CD38 antibody against disseminated human Daudi lymphoma using ¹⁸F-FDG micro Positron Emission Tomography

Laurent D.D. Besret, Sébastien D'Heilly, Alain Selingue, Pascale Lejeune, Patricia Vrignaud, Marie-Christine Bissery, Chantal Carrez

Cancer Res (2010) 70 (8_Supplement): 714.

https://doi.org/10.1158/1538-7445.AM10-714

Published: 15 April 2010

View article titled, Abstract 714: Non-invasive monitoring of the antitumor activity of SAR650984 anti-CD38 antibody against disseminated human Daudi lymphoma using 18F-FDG micro Positron Emission Tomography

Journal Articles

Abstract #2797: In vivo therapeutic synergy of SAR650984, a humanized anti-CD38 antibody, in combination with melphalan in a multiple myeloma xenograft.

Pascale Lejeune, Véronique Blanc, Jacqueline Courta, Coumaran Egile, Patricia Vrignaud, Jutta Deckert, Peter Park, Marie-Christine Bissery

Cancer Res (2009) 69 (9_Supplement): 2797.

Published: 01 May 2009

View article titled, Abstract #2797: In vivo therapeutic synergy of SAR650984, a humanized anti-CD38 antibody, in combination with melphalan in a multiple myeloma xenograft.

Journal Articles

Abstract #859: Broad spectrum of antitumor activity of SAR650984, a humanized anti-CD38 antibody targeting hematological malignancies

Pascale Lejeune, Jutta Deckert, Michele Mayo, Kathy Whiteman, Starrla Johnson, Cheryl Guyre, Véronique Blanc, Peter Park, Robert Lutz, Marie-Christine Bissery, Patricia Vrignaud

Cancer Res (2009) 69 (9_Supplement): 859.

Published: 01 May 2009

View article titled, Abstract #859: Broad spectrum of antitumor activity of SAR650984, a humanized anti-CD38 antibody targeting hematological malignancies

Journal Articles

Broad spectrum of antitumor activity of aflibercept (VEGF Trap) in tumor-bearing mice.

Marielle Chiron, Pascale Lejeune, Friedhelm Bladt, Patricia Vrignaud, Marie-Christine Bissery.

Cancer Res (2008) 68 (9_Supplement): 380.

Published: 01 May 2008

View article titled, Broad spectrum of antitumor activity of aflibercept (VEGF Trap) in tumor-bearing mice.

Journal Articles

Characterization of vascular-disrupting properties of the Combretastatin A4 derivative AVE8062 in the rat aortic ring assay

Marielle Chiron, Joyce Muller, Nicole Diallo, Coumaran Egile, Brigitte Demers, Patricia Vrignaud, Marie-Christine Bissery

Cancer Res (2008) 68 (9_Supplement): 1443.

Published: 01 May 2008

View article titled, Characterization of vascular-disrupting properties of the Combretastatin A4 derivative AVE8062 in the rat aortic ring assay

Journal Articles

Antitumor activity of alvocidib (flavopiridol) in mice bearing human hematological tumors

Claudia Zuany-Amorim, Cecile Combeau, Teresa Granda, Patricia Vrignaud, Marie-Christine Bissery

Cancer Res (2008) 68 (9_Supplement): 752.

Published: 01 May 2008

View article titled, Antitumor activity of alvocidib (flavopiridol) in mice bearing human hematological tumors

Journal Articles

Combination of the antiangiogenic agent aflibercept (VEGF Trap) with docetaxel or gemcitabine results in greater antitumor activity in tumor bearing mice.

Pascale Lejeune, Marielle Chiron, Ronan Le Moigne, Patricia Vrignaud, Marie-Christine Bissery

Cancer Res (2008) 68 (9_Supplement): 1107.

Published: 01 May 2008

View article titled, Combination of the antiangiogenic agent aflibercept (VEGF Trap) with docetaxel or gemcitabine results in greater antitumor activity in tumor bearing mice.

Journal Articles

Demonstration in animal and human of AVE8062-induced tumor blood flow shutdown using dynamic contrast enhanced-ultrasonography (DCE-US).

Erwan Jouannot, Chantal Carrez, Nathalie Lassau, Pascale Lejeune, Brigitte Demers, Patricia Vrignaud, Marie-Christine Bissery

Cancer Res (2007) 67 (9_Supplement): LB-328.

Published: 01 May 2007

View article titled, Demonstration in animal and human of AVE8062-induced tumor blood flow shutdown using dynamic contrast enhanced-ultrasonography (DCE-US).

Journal Articles

In vivo pre-clinical evaluation of the IGF-1R-specific antibody AVE1642 as single agent and in combination with Velcade ^® /Bortezomib

Friedhelm Bladt, Patricia Vrignaud, Stephane Guerif, Noelle Boussac, Thomas Chittenden, Thierry Hercend, Marielle Chiron, Marie-Christine Bissery

Cancer Res (2007) 67 (9_Supplement): 4115.

Published: 01 May 2007

View article titled, In vivo pre-clinical evaluation of the IGF-1R-specific antibody AVE1642 as single agent and in combination with Velcade ® /Bortezomib

Journal Articles

In vivo synergy between trastuzumab (herceptin ^® ) and larotaxel (RPR 109881A), a new taxoid.

Patricia Vrignaud, Marielle Chiron, Murray Stackhouse, Claudia Zuany-Amorim, Helene Goulaouic, Marie-Christine Bissery

Cancer Res (2007) 67 (9_Supplement): 1432.

Published: 01 May 2007

View article titled, In vivo synergy between trastuzumab (herceptin ® ) and larotaxel (RPR 109881A), a new taxoid.

Journal Articles

Pre-clinical evaluation of the anti-tumor activity of the IGF1R - specific anitbody AVE1642

Friedhelm Bladt, Patricia Vrignaud, Marielle Chiron, Corinne Venot, Laurent Debussche, Rajeeva Singh, Thomas Chittenden, Thierry Hercend, Marie-Christine Bissery

Cancer Res (2006) 66 (8_Supplement): 289–290.

Published: 15 April 2006

View article titled, Pre-clinical evaluation of the anti-tumor activity of the IGF1R - specific anitbody AVE1642

Journal Articles

The anti insulin-like growth factor 1 receptor (IGF1-R) antibody AVE1642 exhibits anti-tumor activity against neuroblastoma cell lines and xenografts

Birgit Geoerger, Estelle Daudigeous, Laurent R J Debussche, Corinne Venot, Patricia Vrignaud, Thierry Hercend, Gilles Vassal

Cancer Res (2006) 66 (8_Supplement): 289.

Published: 15 April 2006

View article titled, The anti insulin-like growth factor 1 receptor (IGF1-R) antibody AVE1642 exhibits anti-tumor activity against neuroblastoma cell lines and xenografts

NARROW

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

Abstract 5055: Efficacy of cabazitaxel in mouse models of pediatric brain tumors.

Abstract 5508: Antitumor activity of cabazitaxel in pediatric patient-derived tumor xenografts (PDX).

Abstract LB-34: Similar PI3K and RTK-Ras status in patient derived colorectal cancer-xenografts and patients.

Abstract 2785: Development program of patient tumor tissue bank to support the drug and target discovery.

Abstract 2775: Antitumor activity of cabazitaxel in pediatric tumor xenografts

Abstract 2522: Therapeutic synergism of cabazitaxel in combination with cisplatin in tumor-bearing mice

Abstract 4169: CReMEC initiative: Characterization of patient-derived colorectal tumor models and correlation with patient profile

Abstract 714: Non-invasive monitoring of the antitumor activity of SAR650984 anti-CD38 antibody against disseminated human Daudi lymphoma using ¹⁸F-FDG micro Positron Emission Tomography

Abstract #2797: In vivo therapeutic synergy of SAR650984, a humanized anti-CD38 antibody, in combination with melphalan in a multiple myeloma xenograft.

Abstract #859: Broad spectrum of antitumor activity of SAR650984, a humanized anti-CD38 antibody targeting hematological malignancies

Broad spectrum of antitumor activity of aflibercept (VEGF Trap) in tumor-bearing mice.

Characterization of vascular-disrupting properties of the Combretastatin A4 derivative AVE8062 in the rat aortic ring assay

Antitumor activity of alvocidib (flavopiridol) in mice bearing human hematological tumors

Combination of the antiangiogenic agent aflibercept (VEGF Trap) with docetaxel or gemcitabine results in greater antitumor activity in tumor bearing mice.

Demonstration in animal and human of AVE8062-induced tumor blood flow shutdown using dynamic contrast enhanced-ultrasonography (DCE-US).

In vivo pre-clinical evaluation of the IGF-1R-specific antibody AVE1642 as single agent and in combination with Velcade ^® /Bortezomib

In vivo synergy between trastuzumab (herceptin ^® ) and larotaxel (RPR 109881A), a new taxoid.

Pre-clinical evaluation of the anti-tumor activity of the IGF1R - specific anitbody AVE1642

The anti insulin-like growth factor 1 receptor (IGF1-R) antibody AVE1642 exhibits anti-tumor activity against neuroblastoma cell lines and xenografts

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only